These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 27462459

  • 41. Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development.
    Archbold JK, Flanagan JU, Watkins HA, Gingell JJ, Hay DL.
    Trends Pharmacol Sci; 2011 Oct; 32(10):591-600. PubMed ID: 21722971
    [Abstract] [Full Text] [Related]

  • 42. Receptor activity-modifying protein-dependent impairment of calcitonin receptor splice variant Δ(1-47)hCT((a)) function.
    Qi T, Dong M, Watkins HA, Wootten D, Miller LJ, Hay DL.
    Br J Pharmacol; 2013 Feb; 168(3):644-57. PubMed ID: 22946511
    [Abstract] [Full Text] [Related]

  • 43. Functional characterization of two human receptor activity-modifying protein 3 variants.
    Bailey RJ, Bradley JW, Poyner DR, Rathbone DL, Hay DL.
    Peptides; 2010 Apr; 31(4):579-84. PubMed ID: 20034525
    [Abstract] [Full Text] [Related]

  • 44. Role of the N-terminal domain of the calcitonin receptor-like receptor in ligand binding.
    Chauhan M, Rajarathnam K, Yallampalli C.
    Biochemistry; 2005 Jan 18; 44(2):782-9. PubMed ID: 15641806
    [Abstract] [Full Text] [Related]

  • 45. Novel calcitonin-(8-32)-sensitive adrenomedullin receptors derived from co-expression of calcitonin receptor with receptor activity-modifying proteins.
    Kuwasako K, Kitamura K, Nagoshi Y, Eto T.
    Biochem Biophys Res Commun; 2003 Feb 07; 301(2):460-4. PubMed ID: 12565884
    [Abstract] [Full Text] [Related]

  • 46. Dawn of a New RAMPage.
    Serafin DS, Harris NR, Nielsen NR, Mackie DI, Caron KM.
    Trends Pharmacol Sci; 2020 Apr 07; 41(4):249-265. PubMed ID: 32115276
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Comparison of the expression of calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) with CGRP and adrenomedullin binding in cell lines.
    Choksi T, Hay DL, Legon S, Poyner DR, Hagner S, Bloom SR, Smith DM.
    Br J Pharmacol; 2002 Jul 07; 136(5):784-92. PubMed ID: 12086988
    [Abstract] [Full Text] [Related]

  • 49. Regulation of RAMP expression in diseases.
    Jacob A, Wu R, Wang P.
    Adv Exp Med Biol; 2012 Jul 07; 744():87-103. PubMed ID: 22434110
    [Abstract] [Full Text] [Related]

  • 50. Production of cAMP by adrenomedullin in human oligodendroglial cell line KG1C: comparison with calcitonin gene-related peptide and amylin.
    Uezono Y, Nakamura E, Ueda Y, Shibuya I, Ueta Y, Yokoo H, Yanagita T, Toyohira Y, Kobayashi H, Yanagihara N, Wada A.
    Brain Res Mol Brain Res; 2001 Dec 16; 97(1):59-69. PubMed ID: 11744163
    [Abstract] [Full Text] [Related]

  • 51. Receptor component protein, an endogenous allosteric modulator of family B G protein coupled receptors.
    Routledge SJ, Simms J, Clark A, Yeung HY, Wigglesworth MJ, Dickerson IM, Kitchen P, Ladds G, Poyner DR.
    Biochim Biophys Acta Biomembr; 2020 Mar 01; 1862(3):183174. PubMed ID: 31887275
    [Abstract] [Full Text] [Related]

  • 52. Mammalian calcitonin receptor-like receptor/receptor activity modifying protein complexes define calcitonin gene-related peptide and adrenomedullin receptors in Drosophila Schneider 2 cells.
    Aldecoa A, Gujer R, Fischer JA, Born W.
    FEBS Lett; 2000 Apr 14; 471(2-3):156-60. PubMed ID: 10767413
    [Abstract] [Full Text] [Related]

  • 53. RAMPs as drug targets.
    Sexton PM, Poyner DR, Simms J, Christopoulos A, Hay DL.
    Adv Exp Med Biol; 2012 Apr 14; 744():61-74. PubMed ID: 22434108
    [Abstract] [Full Text] [Related]

  • 54. Functions of third extracellular loop and helix 8 of Family B GPCRs complexed with RAMPs and characteristics of their receptor trafficking.
    Kuwasako K, Hay DL, Nagata S, Murakami M, Kitamura K, Kato J.
    Curr Protein Pept Sci; 2013 Aug 14; 14(5):416-28. PubMed ID: 23745705
    [Abstract] [Full Text] [Related]

  • 55. An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3.
    Muff R, Bühlmann N, Fischer JA, Born W.
    Endocrinology; 1999 Jun 14; 140(6):2924-7. PubMed ID: 10342886
    [Abstract] [Full Text] [Related]

  • 56. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.
    Pawlak JB, Wetzel-Strong SE, Dunn MK, Caron KM.
    Peptides; 2017 Feb 14; 88():1-7. PubMed ID: 27940069
    [Abstract] [Full Text] [Related]

  • 57. The transmembrane domain of receptor-activity-modifying protein 1 is essential for the functional expression of a calcitonin gene-related peptide receptor.
    Steiner S, Muff R, Gujer R, Fischer JA, Born W.
    Biochemistry; 2002 Sep 24; 41(38):11398-404. PubMed ID: 12234182
    [Abstract] [Full Text] [Related]

  • 58. Multiplexed mapping of the interactome of GPCRs with receptor activity-modifying proteins.
    Kotliar IB, Bendes A, Dahl L, Chen Y, Saarinen M, Ceraudo E, Dodig-Crnković T, Uhlén M, Svenningsson P, Schwenk JM, Sakmar TP.
    Sci Adv; 2024 Aug 02; 10(31):eado9959. PubMed ID: 39083597
    [Abstract] [Full Text] [Related]

  • 59. RAMPs: 5 years on, where to now?
    Morfis M, Christopoulos A, Sexton PM.
    Trends Pharmacol Sci; 2003 Nov 02; 24(11):596-601. PubMed ID: 14607083
    [Abstract] [Full Text] [Related]

  • 60. International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors.
    Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fischer JA, Foord SM.
    Pharmacol Rev; 2002 Jun 02; 54(2):233-46. PubMed ID: 12037140
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.